Business View Magazine Jan-2019

161 across a panorama of foods and drugs. But we’re trying to get themmore resources and get them focused on taking some low-hanging fruit out of the marketplace so that responsible companies can enter the fray with products that are made accord- ing to the good manufacturing practices that are on the books. “There are too many people that are getting into the business, claiming that their products are di- etary supplements, but they’re either knowingly, or naively, including active pharmaceutical ingredients and not disclosing those.There are a lot of internet- purveyors of products that seem to turn a blind eye towards the regulatory and oversight requirements. And those present an enormous risk to the public. So the NPA is working with the FDA and others to try and identify these products and get them seized at the border or, to stop production in the United States through a judicious application of regulatory oversight.And in our discussions with the Federal Trade Commission (FTC) and the FDA, and Health and Human Services, those are some pretty signifi- cant issues that I think the administration needs to deal with. But, again, they’re resource-constrained, and to the extent that we can get more resources so that they can pursue their stated objectives and what they’re supposed to do, I think it will benefit the consumers and the industry at large.” BVM: What’s the long-term outlook for NAI? Le Doux: “I think the demographics are on our side and the science is on our side.We have an enor-